Bridging over the troubled heterogeneity of SPG-related pathologies: Mechanisms unite what genetics divide

Current Molecular Medicine

Volumn 14, Issue 8, 2014, Pages 1034-1042

  Tessa, A ^a   Denora, P S ^b   Racis, L ^b   Storti, E ^a   Orlacchio, A ^c,d   Santorelli, F M ^a  

^a DEPARTMENT OF DEVELOPMENTAL NEUROSCIENCE   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

^d UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Genetic; Genotype phenotype correlations; Hereditary spastic paraplegia; Heterogeneity; Mechanisms of disease; Mutation; SPG

Indexed keywords

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE DISORDER; CELL MIGRATION; GENE MUTATION; GENETIC HETEROGENEITY; GENOTYPE PHENOTYPE CORRELATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; NERVE FIBER TRANSPORT; NEUROIMAGING; NONHUMAN; PATHOGENESIS; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; SPASTIC GAIT;

EID: 84911492221     PISSN: 15665240     EISSN: 18755666     Source Type: Journal    
DOI: 10.2174/1566524014666141010154526     Document Type: Article

References (85)

1. Harding AE. Classification of the hereditary ataxias and paraplegias. Lancet 1983; 1: 1151-1155.
2. Coutinho P, Ruano L, Loureiro JL, et al. Hereditary ataxia and spastic paraplegia in Portugal: a population-based prevalence study. JAMA Neurol 2013; 70: 746-755.
3. Erichsen AK, Koht J, Stray-Pedersen A, Abdelnoor M, Tallaksen CM. Prevalence of hereditary ataxia and spastic paraplegia in southeast Norway: a population-based study. Brain 2009; 132: 1577-1588.
4. Fink JK. Hereditary Spastic Paraplegia Overview. 2000 Aug 15 [updated 2009 Feb03]. n: Pagon RA, Bird TD, Dolan CR, Stephens K, editors. GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle; 1993.
5. Durr A, Camuzat A, Colin E, et al. Atlastin1 mutations are frequent in young-onset autosomal dominant spastic paraplegia. Arch Neurol 2004; 61: 1867-1872.
6. Varga RE, Schüle R, Fadel H, et al. Do Not Trust the Pedigree: Reduced and Sex-Dependent Penetrance at a Novel Mutation Hotspot in ATL1 Blurs Autosomal Dominant Inheritance of Spastic Paraplegia. Hum Mutat 2013; 34: 860-863.
7. Svenson IK, Kloos MT, Gaskell PC, et al. Intragenic modifiers of hereditary spastic paraplegia due to spastin gene mutations. Neurogenetics 2004; 5: 157-164.
8. Ribai P, Depienne C, Fedirko E, et al. Mental deficiency in three families with SPG4 spastic paraplegia. Eur J Hum Genet 2008; 16: 97-104.
9. Depienne C, Stevanin G, Brice A, Durr A. Hereditary spastic paraplegias: an update. Curr Opin Neurol 2007; 20: 674-680.
10. de Bot ST, van de Warrenburg BP, Kremer HP, Willemsen MA. Child neurology: hereditary spastic paraplegia in children. Neurology 2010; 75: e75-e79.
11. Xia CH, Roberts Ea, Her LS, et al. Abnormal neurofilament transport caused by targeted disruption of neuronal kinesin heavy chain KIF5A. J Cell Biol 2003; 161: 55-66.
12. Ferreirinha F, Quattrini A, Pirozzi M, et al. Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport. J Clin Invest 2004; 113: 231-242.
13. Sherwood NT, Sun Q, Xue M, et al. Drosophila spastin regulates synaptic microtubule networks and is required for normal motor function. PLoS Biol 2004; 2: e429.
14. Tarrade A, Fassier C, Courageot S, et al. A mutation of spastin is responsible for swellings and impairment of transport in a region of axon characterized by changes in microtubule composition. Hum Mol Genet 2006; 15: 3544-3558.
15. Wood JD, Landers JA, Bingley M, et al. The microtubule-severing protein spastin is essential for axon outgrowth in the zebrafish embryo. Hum Mol Genet 2006; 15: 2763-2771.
16. Matsushita-Ishiodori Y, Yamanaka K, Ogura T. The C. elegans homologue of the spastic paraplegia protein, spastin, disassembles microtubules. Biochem Biophys Res Commun 2007; 359: 157-162.
17. Blackstone C. Cellular pathways of hereditary spastic paraplegia. Annu Rev Neurosci 2012; 35: 25-47.
18. Bruyn RP. The neuropathology of hereditary spastic paraparesis. Clin Neurol Neurosurg 1992; 94: S16-S18.
19. França MC Jr, Yasuda CL, Pereira FR, et al. White and grey matter abnormalities in patients with SPG11 mutations. J Neurol Neurosurg Psychiatry 2012; 83: 828-833.
20. Shibasaki Y, Tanaka H, Iwabuchi K, et al. Linkage of autosomal recessive hereditary spastic paraplegia with mental impairment and thin corpus callosum to chromosome 15q13-15. Ann Neurol 2000; 48: 108-112.
21. França MC Jr, D'Abreu A, Maurer-Morelli CV, et al. Prospective neuroimaging study in hereditary spastic paraplegia with thin corpus callosum. Mov Disord 2007; 22: 1556-1562.
22. Stevanin G, Santorelli FM, Azzedine H, et al. Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum. Nat Genet 2007; 39: 366-372.
23. Verny C, Guegen N, Desquiret V, et al. Hereditary spastic paraplegia-like disorder due to a mitochondrial ATP6 gene point mutation. Mitochondrion 2011; 11: 70-75.
24. Polo JM, Calleja J, Combarros O, et al. Hereditary ataxias and paraplegias in Cantabria, Spain. An epidemiological and clinical study. Brain 1991; 114: 855-866.
25. Boukhris A, Stevanin G, Feki I, et al. Hereditary spastic paraplegia with mental impairment and thin corpus callosum in Tunisia: SPG11, SPG15 and further genetic heterogeneity. Arch Neurol 2008; 65: 393-402.
26. Wang JM, Wu Y, Wang HF, et al. Proteolipid protein 1 gene mutation in nine patients with Pelizaeus-Merzbacher disease. Chin Med J (Engl) 2008; 121: 1638-1642.
27. McDermott CJ, Grierson AJ, Wood JD, et al. Hereditary spastic paraparesis: disrupted intracellular transport associated with spastin mutation. Ann Neurol 2003; 54: 748-759.
28. Orlacchio A, Patrono C, Borreca A, et al. Spastic paraplegia in Romania: high prevalence of SPG4 mutations. J Neurol Neurosurg Psychiatry 2007; 79: 606-607.
29. Rainier S, Sher C, Reish O, et al. De novo occurrence of novel SPG3A/atlastin mutation presenting as cerebral palsy. Arch Neurol 2006; 63: 445-447.
30. Meijer IA, Dion P, Laurent S, et al. Characterization of a novel SPG3A deletion in a French-Canadian family. Ann Neurol 2007; 61: 599-603.
31. Namekawa M, Ribai P, Nelson I, et al. SPG3A is the most frequent cause of hereditary spastic paraplegia with onset before age 10 years. Neurology 2006; 66: 112-114.
32. Valdmanis PN, Meijer IA, Reynolds A, et al. Mutations in the KIAA0196 gene at the SPG8 locus cause hereditary spastic paraplegia. Am J Hum Genet 2007; 80: 152-161.
33. Windpassinger C, Auer-Grumbach M, Irobi J, et al. Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome. Nat Genet 2004; 36: 271-276.
34. Montenegro G, Rebelo AP, Connell J, et al. Mutations in the ER-shaping protein reticulon 2 cause the axon-degenerative disorder hereditary spastic paraplegia type 12. J Clin Invest 2012; 122: 538-544.
35. Seri M, Cusano R, Forabosco P, et al. Genetic mapping to 10q23. 3-q24. 2, in a large Italian pedigree, of a new syndrome showing bilateral cataracts, gastroesophageal reflux, and spastic paraparesis with amyotrophy. Am J Hum Genet 1999; 64: 586-593.
36. Tsaousidou MK, Ouahchi K, Warner TT, et al. Sequence alterations within CYP7B1 implicate defective cholesterol homeostasis in motor-neuron degeneration. Am J Hum Genet 2008; 82: 510-515.
37. Schüle R, Brandt E, Karle KN, et al. Analysis of CYP7B1 in non-consanguineous cases of hereditary spastic paraplegia. Neurogenetics 2009; 10: 97-104.
38. Biancheri R, Ciccolella M, Rossi A, et al. White matter lesions in spastic paraplegia with mutations in SPG5/CYP7B1. Neuromuscul Disord 2009; 19: 62-65.
39. Klebe S, Durr A, Bouslam N, et al. Spastic paraplegia 5: locus refinement, candidate gene analysis and clinical description. Am J Med Genet B Neuropsychiatr Genet 2007; 144: 854-861.
40. Arnoldi A, Tonelli A, Crippa F, et al. A clinical, genetic, and biochemical characterization of SPG7 mutations in a large cohort of patients with hereditary spastic paraplegia. Hum Mutat 2008; 29: 522-531.
41. Elleuch N, Depienne C, Benomar A, et al. Mutation analysis of the paraplegin gene (SPG7) in patients with hereditary spastic paraplegia. Neurology 2006; 66: 654-659.
42. Warnecke T, Duning T, Schwan A, et al. A novel form of autosomal recessive hereditary spastic paraplegia caused by a new SPG7 mutation. Neurology 2007; 69: 368-375.
43. Brugman F, Scheffer H, Wokke JH, et al. Paraplegin mutations in sporadic adult-onset upper motor neuron syndromes. Neurology 2008; 71: 1500-1505.
44. Klebe S, Depienne C, Gerber S, et al. Spastic paraplegia gene 7 in patients with spasticity and/or optic neuropathy. Brain 2012; 135: 2980-2993.
45. Denora PS, Schlesinger D, Casali C, et al. Screening of ARHSP-TCC patients expands the spectrum of SPG11 mutations and includes a large scale gene deletion. Hum Mutat 2009; 30: E500-19.
46. Riverol M, Samaranch L, Pascual B, et al. Forceps minor region signal abnormality "ears of the lynx": an early MRI finding in spastic paraparesis with thin corpus callosum and mutations in the spatacsin gene (SPG11) on chromosome 15. J Neuroimaging 2009; 1: 52-60.
47. Stevanin G, Azzedine H, Denora P, et al. Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration. Brain 2008; 131: 772-784.
48. Hanein S, Martin E, Boukhris A, et al. Identification of the SPG15 gene, encoding spastizin, as a frequent cause of complicated autosomal recessive spastic paraplegia including Kjellin syndrome. Am J Hum Genet 2008; 82: 992-1002.
49. Denora PS, Muglia M, Casali C, et al. Spastic paraplegia with thinning of the corpus callosum and white matter abnormalities: Further mutations and relative frequency in ZFYVE26/SPG15 in the Italian population. J Neurol Sci 2009; 277: 22-25.
50. Orlacchio A, Kawarai T, Totaro A, et al. Hereditary spastic paraplegia: clinical genetic study of 15 families. Arch Neurol 2004; 61: 849-855.
51. Schüle R, Schöls L. Genetics of hereditary spastic paraplegias. Semin Neurol 2011; 31: 484-493.
52. Fink JK, Heiman-Patterson T, Bird T, et al. Hereditary spastic paraplegia: advances in genetic research. Hereditary Spastic Paraplegia Working Group. Neurology 1996; 46: 1507-1514.
53. Depienne C, Tallaksen C, Lephay JY, et al. Spastin mutations are frequent in sporadic spastic paraparesis and their spectrum is different from the one observed in familial cases. J Med Genet 2006; 43: 259-265.
54. Ebbing B, Mann K, Starosta A, et al. Effect of spastic paraplegia mutations in KIF5A kinesin on transport activity. Hum Mol Genet 2008; 17: 1245-1252.
55. White SR, Evans KJ, Lary J, et al. Recognition of C-terminal amino acids in tubulin by pore loops in spastin is important for microtubule severing. J Cell Biol 2007; 176: 995-1005.
56. Errico A, Claudiani P, D'Addio M, Rugarli EI. Spastin interacts with the centrosomal protein NA14, and is enriched in the spindle pole, the midbody and the distal axon. Hum Mol Genet 2004; 13: 2121-2132.
57. Trotta N, Orso G, Rossetto MG, et al. The hereditary spastic paraplegia gene, spastin, regulates microtubule stability to modulate synaptic structure and function. Curr Biol 2004; 14: 1135-1147.
58. Salinas S, Carazo-Salas RE, Proukakis C, et al. Human spastin has multiple microtubule-related functions. J Neurochem 2005; 95: 1411-1420.
59. Yu W, Qiang L, Solowska JM, et al. The microtubule-severing proteins spastin and katanin participate differently in the formation of axonal branches. Mol Biol Cell 2008; 19: 1485-1498.
60. Evans K, Keller C, Pavur K, et al. Interaction of two hereditary spastic paraplegia gene products, spastin and atlastin, suggests a common pathway for axonal maintenance. Proc Natl Acad Sci U S A 2006; 103: 10666-10671.
61. Sanderson CM, Connell JW, Edwards TL, et al. Spastin and atlastin, two proteins mutated in autosomal-dominant hereditary spastic paraplegia, are binding partners. Hum Mol Genet 2006; 15: 307-318.
62. Rismanchi N, Soderblom C, Staedler J, et al. Atlastin GTPase are required for Golgi apparatus and ER morphogenesis. Hum Mol Genet 2008; 17: 1591-1604.
63. Goytain A, Hines RM, El Husseini A, et al. NIPA1 (SPG6), the basis for autosomal dominant form of hereditary spastic paraplegia, encodes a functional Mg2+ transporter. J Biol Chem 2007; 282: 8060-8068.
64. Tsang HT, Edwards TL, Wang X, et al. The hereditary spastic paraplegia proteins NIPA1, spastin and spartin are inhibitors of mammalian BMP signalling. Hum Mol Genet 2009; 18: 3805-3821.
65. Lu J, Rashid F, Byrne PC. The hereditary spastic paraplegia protein spartin localises to mitochondria. J Neurochem 2006; 98: 1908-1919.
66. Robay D, Patel H, Simpson MA, et al. Endogenous spartin, mutated in hereditary spastic paraplegia, has a complex subcellular localization suggesting diverse roles in neurons. Exp Cell Res 2006; 312: 2764-2777.
67. Joshi DC, Bakowska JC. SPG20 protein spartin associates with cardiolipin via its plant-related senescence domain and regulates mitochondrial Ca2 + homeostasis. PLoS One 2011; 6: e19290.
68. Murmu RP, Martin E, Rastetter A, et al. Cellular distribution and subcellular localization of spatacsin and spastizin, two proteins involved in hereditary spastic paraplegia. Mol Cell Neurosci 2011; 47: 191-202.
69. Hirst J, Barlow LD, Francisco GC, et al. The fifth adaptor protein complex. PLoS Biol 2011; 9: e1001170.
70. Hehr U, Bauer P, Winner B, et al. Long-term course and mutational spectrum of spatacsin-linked spastic paraplegia. Ann Neurol 2007; 62: 656-665.
71. Casari G, De Fusco M, Ciarmatori S, et al. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell 1998; 93: 973-983.
72. Nolden M, Ehses S, Koppen M, et al. The m-AAA protease defective in hereditary spastic paraplegia controls ribosome assembly in mitochondria. Cell 2005; 123: 277-289.
73. Wilkinson PA, Crosby AH, Turner C, et al. A clinical, genetic and biochemical study of SPG7 mutations in hereditary spastic paraplegia. Brain 2004; 127: 973-980.
74. Pirozzi M, Quattrini A, Andolfi G, et al. Intramuscular viral delivery of paraplegin rescues peripheral axonopathy in a model of hereditary spastic paraplegia. J Clin Invest 2006; 116: 202-208.
75. Koppen M, Metodiev MD, Casari G, et al. Variable and tissue-specific subunit composition of mitochondrial m-AAA protease complexes linked to hereditary spastic paraplegia. Mol Cell Biol 2007; 27: 758-767.
76. Hansen J, Coryden TJ, Palmfeldt J, et al. Decreased expression of mitochondrial matrix proteases Lon and ClpP in cells from patient with hereditary spastic paraplegia (SPG13). Neuroscience 2008; 153: 474-482.
77. Gupta S, Knowlton AA. Cytosolic heat shock protein 60, hypoxia, and apoptosis. Circulation 2002; 106: 2727-2733.
78. Zuchner S, Wang G, Tran-Viet KN, et al. Mutations in the novel mitochondrial protein REEP1 cause hereditary spastic paraplegia type 31. Am J Hum Genet 2006; 79: 365-369.
79. Dahme M, Bartsch U, Martini R, et al. Disruption of the mouse L1 gene leads to malformations of the nervous system. Nat Genet 1997; 17: 346-349.
80. Garbern JY, Yool DA, Moore GJ, et al. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 2002; 125: 551-561.
81. Hölttä-Vuori M, Salo VT, Ohsaki Y, Suster ML, Ikonen E. Alleviation of seipinopathy-related ER stress by triglyceride storage. Hum Mol Genet 2013; 22: 1157-1166.
82. Rainier S, Bui M, Mark E, et al. Neuropathy target esterase gene mutations cause motor neuron disease. Am J Hum Genet 2008; 82: 780-785.
83. Tesson C, Nawara M, Salih MA, et al. Alteration of fatty-acid-metabolizing enzymes affects mitochondrial form and function in hereditary spastic paraplegia. Am J Hum Genet 2012; 91: 1051-1064.
84. Gebremedhin D, Lange AR, Narayanan J, Aebly MR, Jacobs ER, Harder DR. Cat cerebral arterial smooth muscle cells express cytochrome P450 4A2 enzyme and produce the vasoconstrictor 20-HETE which enhances L-type Ca2+ current. J Physiol 1998; 507: 771-781.
85. Sung J, Wang Y, Chandrasekaran S, Witten DM, Price ND. Molecular signatures from omics data: from chaos to consensus. Biotechnol J 2012; 7: 946-957.